Cytomegalovirus (CMV) Phosphoprotein 65 Makes a Large Contribution to Shaping the T Cell Repertoire in CMV‐Exposed IndividualsFlorian Kern, Louis J. Picker, Axel Prüß et al.|The Journal of Infectious Diseases|2002Cited by 280
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trialsAxel Hauschild, Paul B. Chapman, Paolo A. Ascierto et al.|European Journal of Cancer|2020Cited by 69
Updated 5-y landmark analyses of phase 2 (BREAK-2) and phase 3 (BREAK-3) studies evaluating dabrafenib monotherapy in patients with <i>BRAF</i> V600–mutant melanoma.Paul B. Chapman, Axel Hauschild, Paolo A. Ascierto et al.|Journal of Clinical Oncology|2017Cited by 6